The 14‐day repeated‐dose toxicity studies of a fixed‐dose combination, QXOH/levobupivacaine, via subcutaneous injection in mice
- 5 April 2021
- journal article
- research article
- Published by Wiley in Journal of Applied Toxicology
- Vol. 41 (11) , 1747-1764
Abstract
QXOH‐LB, a fixed‐dose combination (35 mM QXOH and 10 mM levobupivacaine) has been shown to induce a long duration of local anesthesia in animal efficacy testing, which indicates potential for postoperative pain management. In this study, we evaluated the potential toxicity of QXOH‐LB in NIH mice under the Guidance on the repeated‐dose toxicity published by the China Food and Drug Administration. Mice (n = 30 per sex per group) were subcutaneously injected 5, 10, 20 mg/kg QXOH‐LB, 5, 10, 20 mg/kg QXOH, and 5 mg/kg levobupivacaine (LB) once a day for 14 days with sacrifice of main study animals; remaining mice (n = 10 per sex per group) were monitored for an additional 4‐week recovery period. Mice in the 10 and 20 mg/kg QXOH, and 20 mg/kg QXOH‐LB died, which was considered due to excessive respiratory inhibition. The doses of 10 mg/kg QXOH‐LB and 5 mg/kg QXOH were well tolerated without any clinical signs of toxicity. Therefore, the no‐observed‐adverse‐effect level (NOAEL) of QXOH‐LB and QXOH was considered to be 10 and 5 mg/kg/day, respectively. In the dose range from 5 to 20 mg/kg, the exposure of QXOH and LB in QXOH‐LB was equal to each agent used alone at the same dose in NIH mice. There was no gender difference on exposure and no evidence of accumulation.Keywords
Funding Information
- West China Hospital, Sichuan University (2019HXBH012)
- Sichuan Provincial Science and Technology Support Program (2020YJ0053)
- China Postdoctoral Science Foundation (2020M673235)
This publication has 28 references indexed in Scilit:
- 1–year follow–up of 920 hip and knee arthroplasty patients after implementing fast–trackActa Orthopaedica, 2014
- Multivesicular liposomal bupivacaine at the sciatic nerveBiomaterials, 2014
- Bupivacaine‐induced cellular entry of QX‐314 and its contribution to differential nerve blockBritish Journal of Pharmacology, 2013
- Practice Guidelines for Acute Pain Management in the Perioperative SettingAnesthesiology, 2012
- Duration and Local Toxicity of Sciatic Nerve Blockade With Coinjected Site 1 Sodium-Channel Blockers and Quaternary Lidocaine DerivativesRegional Anesthesia & Pain Medicine, 2012
- QX-314 Produces Long-lasting Local Anesthesia Modulated by Transient Receptor Potential Vanilloid Receptors in MiceAnesthesiology, 2009
- The Quaternary Lidocaine Derivative, QX-314, Produces Long-lasting Local Anesthesia in Animal Models In VivoAnesthesiology, 2007
- Acute Toxicity of Local AnestheticsRegional Anesthesia & Pain Medicine, 2005
- A Functional Observational Battery for Use in Canine Toxicity Studies: Development and ValidationInternational Journal of Toxicology, 2003
- Adverse Effects and Drug Interactions Associated with Local and Regional AnaesthesiaDrug Safety, 1998